|
Friday | April 7, 2023 | 12:00 pm - 1:00 pm ET
NOTE: If you are unable to attend the live webinar, it will be archived within two weeks on the PCSS website (https://bit.ly/PCSSarchive).
Presenter: Brian Hurley, MD, MBA, DFASAM, FAPA
Cost: No Fee
Target audience: Nurses, Addictions Specialists, SUD Project Directors, Managers, and Facilitators and MOUD (medications for opioid use disorder) providers
Credit Designations Available: Nursing CE
Webinar description: This webinar will review variations on buprenorphine dosing that can be considered for patients with opioid use disorder involving fentanyl. The presenters will review the evidence for and describe low dose buprenorphine initiation of protocols, high dose buprenorphine initiation of protocols, approaches to help support patients stop using full agonist opioids for a longer period of time, and a clinical approach to referring patients to alternative medications for opioid use disorder.
Educational objectives: At the conclusion of this activity participants should be able to:
- Compare and contrast low-dose, high-dose, standard dose, and variations for the timing and setting for initiating buprenorphine to treat opioid use disorder involving fentanyl.
- Design a treatment plan that factors in the risks and benefits of buprenorphine to treat opioid use disorder in consideration of the set, setting, and patient’s priorities for their opioid use disorder treatment.
- Recognize the limitations of buprenorphine treatment of opioid use disorder and how to refer to alternative treatments.
Credit education information: This course has been approved by the California Board of Registered Nursing, provider #CEP16785, for a maximum of 1.00 Nursing CE. The licensee must retain this document for a period of four (4) years after the course concludes.
| 
